Afficher la notice abrégée

Nutraceutical Approaches to Cardiovascular and Metabolic Diseases: Evidence and Opportunities

dc.contributor.editorMagni, Paolo
dc.contributor.editorBaragetti, Andrea
dc.contributor.editorPoli, Andrea
dc.date.accessioned2023-04-05T13:03:37Z
dc.date.available2023-04-05T13:03:37Z
dc.date.issued2023
dc.identifierONIX_20230405_9783036571300_279
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/99000
dc.description.abstractA major task for health professionals and health systems is effectively preventing and treating cardiovascular and metabolic diseases. This reprint offers an updated set of experimental and clinical information on the usefulness of nutraceutical products for the management of cardiometabolic diseases, which range from obesity and diabetes mellitus and their complications to hypercholesterolemia. The nutraceutical option may be used according the “beyond diet, before drug” strategy and is particularly relevant in the cardiometabolic field. The chapters of this reprint offer a deep insight into relevant issues in this nutraceutical field, such as experimental research for the preclinical identification of interesting compounds of natural origin, quality of nutraceutical products and their efficacy and safety, regulatory aspects, and the quality of evidence-based medicine.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciencesen_US
dc.subject.classificationthema EDItEUR::J Society and Social Sciences::JB Society and culture: general::JBC Cultural and media studies::JBCC Cultural studies::JBCC4 Cultural studies: food and societyen_US
dc.subject.otherAtherosclerotic Cardiovascular Diseases
dc.subject.otherGut Microbiota
dc.subject.othernext generation sequencing
dc.subject.otheroxysterols
dc.subject.other24-OHC
dc.subject.other25-OHC
dc.subject.other27-OHC
dc.subject.othercholesterol metabolism
dc.subject.otherprobiotic
dc.subject.othercardiovascular risk
dc.subject.otherhypercholesterolemia
dc.subject.othermonacolin K
dc.subject.othernutraceutical
dc.subject.othervery-low calorie ketogenic diet
dc.subject.otherobesity
dc.subject.otherinsulin resistance
dc.subject.otherdiabetic retinopathy
dc.subject.othermacular xanthophylls
dc.subject.othercarotenoids
dc.subject.othermacular pigment
dc.subject.othermacular pigment optical density
dc.subject.otherMPOD
dc.subject.otherlutein
dc.subject.otherzeaxanthin
dc.subject.othermeso-zeaxanthin
dc.subject.otherdiabetes
dc.subject.otherretinal neurodegeneration
dc.subject.otherneuroprotection
dc.subject.otherphytosterols
dc.subject.otherplant sterols
dc.subject.othercholesterol
dc.subject.othercardiovascular disease
dc.subject.othersupplements
dc.subject.otherfunctional foods
dc.subject.otherPREDIMED
dc.subject.otherMediterranean diet
dc.subject.otherlipid profile
dc.subject.otherpolyphenols
dc.subject.othermenopause
dc.subject.otherbody fat
dc.subject.otherbiomarkers
dc.subject.othertartaric acid
dc.subject.othernutraceuticals
dc.subject.otherdyslipidaemia
dc.subject.otheratherosclerosis
dc.subject.othertree nuts
dc.subject.otherpeanuts
dc.subject.otherfatty acids
dc.subject.otherprospective studies
dc.subject.otherrandomized clinical trials
dc.subject.othertype-2 diabetes
dc.subject.othercancer
dc.subject.otherhypertension
dc.subject.othercognitive function
dc.subject.othermortality
dc.subject.otherbody weight
dc.subject.otherblood lipids
dc.subject.otherinflammation
dc.subject.otherdietary lipids
dc.subject.otherimmune-inflammation
dc.subject.othermicrobiota
dc.subject.otherCameroonian spice extracts
dc.subject.otherSW 872 adipocytes
dc.subject.othertriglyceride accumulation
dc.subject.otherglucose uptake
dc.subject.otheroxidative stress
dc.subject.otherpro-inflammatory cytokines
dc.subject.otherPrunus domestica L.
dc.subject.otherchemical characterization
dc.subject.otherdigestive enzyme inhibition
dc.subject.otherHMG-CoA reductase inhibition
dc.subject.otheranti-inflammatory activity
dc.subject.otherguidelines
dc.subject.othernutraceutical product
dc.subject.othermetabolic disease
dc.subject.othertype 2 diabetes mellitus
dc.subject.othern/a
dc.titleNutraceutical Approaches to Cardiovascular and Metabolic Diseases: Evidence and Opportunities
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-7131-7
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036571300
oapen.relation.isbn9783036571317
oapen.pages214
oapen.place.publicationBasel


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/